The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia.

The aim of this study was to observe the effect of folate and antioxidants alone on homocysteine levels and oxidative stress markers, and to evaluate whether their co-administration promotes their effects. One hundred patients with hyperhomocysteinemia were randomized into four equal groups, which were then treated with folate, antioxidants or folate plus antioxidants for 2 months; group IV was a control group. Serum homocysteine, folate and oxidative stress markers were measured before the study, at the end of folate and/or antioxidants administration and 3 months later. Folate caused a significant decrease in homocysteine concentration. Antioxidants did not influence homocysteine concentration, but they improved the antioxidative defense (plasma antioxidant capacity and intraerythrocyte glutathione were increased) and partially prevented lipid peroxidation (malondialdehyde level was slightly decreased). Supplementation with folate had a similar effect on intracellular glutathione and plasma malondialdehyde. Simultaneous administration of folate and antioxidants did not show any additive effect with the exception of a slower decrease of folate concentration after its supplementation had been discontinued. Folate may be considered as an effective antioxidant in patients with hyperhomocysteinemia; this can be a result of decreased production of free radicals due to a reduced level of homocysteine. Its antioxidative effect cannot be promoted by co-administration of antioxidants.

[1]  J. Juncà,et al.  Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  D. Wilcken,et al.  Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.

[3]  D. Bunout,et al.  Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. , 2000, Nutrition.

[4]  J. Bonham,et al.  Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity , 2000, Free radical research.

[5]  A. Blann,et al.  Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction , 1999, British journal of haematology.

[6]  A. M. Lefer,et al.  Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. , 1999, General pharmacology.

[7]  A. Sidawy,et al.  Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells. , 1999, Journal of vascular surgery.

[8]  P. Jacques,et al.  Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  W. Zidek,et al.  Evidence of Altered Homocysteine Metabolism in Chronic Renal Failure , 1999, Nephron.

[10]  R. Marfella,et al.  Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. , 1999, JAMA.

[11]  P. Wilson,et al.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.

[12]  J. Morrow,et al.  Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  C. Luley,et al.  Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease. , 1999, Metabolism: clinical and experimental.

[14]  M. Ushio-Fukai,et al.  Redox control of vascular smooth muscle proliferation. , 1998, The Journal of laboratory and clinical medicine.

[15]  M. Lucock,et al.  The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study , 1998, European Journal of Clinical Nutrition.

[16]  C. Iadecola,et al.  Superoxide-dependent cerebrovascular effects of homocysteine. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  L. Fink,et al.  Oxidative Stress in Diabetic Macrovascular Disease: Does Homocysteine Play a Role? , 1997, Southern medical journal.

[18]  P. Ueland,et al.  Elevated plasma levels of reduced homocysteine in common variable immunodeficiency — a marker of enhanced oxidative stress , 1997, European journal of clinical investigation.

[19]  Yasuhiro Watanabe,et al.  Homocysteine as a modulator of platelet‐derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide , 1997, British journal of pharmacology.

[20]  S. Lentz,et al.  Homocysteine and vascular dysfunction. , 1997, Life sciences.

[21]  A. Szczeklik,et al.  Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation. , 1997, Thrombosis research.

[22]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[23]  D. Kennedy,et al.  Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs. , 1997, Atherosclerosis.

[24]  Won‐Ki Kim,et al.  Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture , 1996, Neuroscience Letters.

[25]  L. Brattström.  Vitamins as homocysteine-lowering agents. , 1996, The Journal of nutrition.

[26]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[27]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[28]  A. Lindgren,et al.  Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid , 1995, Journal of internal medicine.

[29]  H. Blom,et al.  Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemia , 1995, European journal of clinical investigation.

[30]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[31]  J. Witztum,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[32]  B. Jones,et al.  Lipid peroxidation and homocysteine induced toxicity. , 1994, Atherosclerosis.

[33]  K. Mccully.  Chemical pathology of homocysteine. I. Atherogenesis. , 1993, Annals of clinical and laboratory science.

[34]  B. Hultberg,et al.  Plasma homocysteine in renal failure. , 1993, Clinical nephrology.

[35]  P. Ueland,et al.  Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.

[36]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[37]  J. Kooner,et al.  Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy Demonstration of Rapid Onset Vascular Endothelial Dysfunction After , 1999 .

[38]  P. Jungers,et al.  Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. , 1996, Mineral and electrolyte metabolism.

[39]  P. Fürst,et al.  Improved analysis of malondialdehyde in human body fluids. , 1996, Free radical biology & medicine.